Valuation
- Market cap
- 0
- Revenue TTM
- $1,070,000
- Net income TTM
- $-8,250,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -771.03%
- Debt to equity
- 0.00
Trading
- Volume
- 3,500
- Avg volume
- —
- Day's range
- $0.06 – $0.06
- Shares out
- —
- Stochastic %K
- —
- Beta
- 0.40
- Analysts
- —
- Price target
- —
Company profile
Vitasora Health Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. It also provides critical patient health tracking services to clinicians and healthcare teams. The...
Show more
Vitasora Health Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. It also provides critical patient health tracking services to clinicians and healthcare teams. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company was incorporated in 1987 and is based in Melbourne, Australia.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 61 3 9653 9160
- Website
- https://respiri.co
- Address
- 432 St Kilda Road, Suite 1, Level 9, Melbourne, Australia
Latest news
No headlines yet.
